BioCryst Pharmaceuticals Inc (BCRX)
4.515
+0.02
(+0.33%)
USD |
NASDAQ |
Apr 19, 09:36
BioCryst Pharmaceuticals Shares Outstanding: 206.15M for Feb. 23, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 23, 2024 | 206.15M |
December 31, 2023 | 205.77M |
October 31, 2023 | 204.81M |
September 30, 2023 | 189.80M |
July 28, 2023 | 189.49M |
June 30, 2023 | 189.49M |
April 28, 2023 | 188.93M |
April 17, 2023 | 188.92M |
March 31, 2023 | 188.88M |
January 31, 2023 | 188.45M |
December 31, 2022 | 187.91M |
October 31, 2022 | 186.42M |
September 30, 2022 | 186.41M |
July 29, 2022 | 185.94M |
June 30, 2022 | 185.88M |
April 29, 2022 | 185.58M |
April 11, 2022 | 185.58M |
March 31, 2022 | 185.57M |
January 31, 2022 | 184.66M |
December 31, 2021 | 184.35M |
October 29, 2021 | 179.94M |
September 30, 2021 | 179.79M |
August 06, 2021 | 178.87M |
July 30, 2021 | 178.87M |
June 30, 2021 | 178.73M |
Date | Value |
---|---|
April 30, 2021 | 177.70M |
March 31, 2021 | 177.67M |
March 30, 2021 | 177.65M |
February 24, 2021 | 177.52M |
January 31, 2021 | 177.18M |
December 31, 2020 | 176.88M |
October 31, 2020 | 176.57M |
September 30, 2020 | 176.57M |
July 31, 2020 | 176.57M |
June 30, 2020 | 176.43M |
June 01, 2020 | 176.40M |
May 26, 2020 | 154.36M |
April 30, 2020 | 154.25M |
April 22, 2020 | 154.26M |
March 31, 2020 | 154.19M |
March 20, 2020 | 154.19M |
January 31, 2020 | 154.19M |
December 31, 2019 | 154.08M |
November 19, 2019 | 154.06M |
November 18, 2019 | 154.06M |
November 11, 2019 | 110.44M |
October 31, 2019 | 110.44M |
September 30, 2019 | 110.44M |
July 31, 2019 | 110.44M |
June 30, 2019 | 110.37M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
110.31M
Minimum
Apr 30 2019
206.15M
Maximum
Feb 23 2024
170.44M
Average
177.70M
Median
Apr 30 2021
Shares Outstanding Benchmarks
AIM ImmunoTech Inc | 49.90M |
Perspective Therapeutics Inc | 586.92M |
Protalix BioTherapeutics Inc | 73.05M |
Electromed Inc | 8.605M |
Armata Pharmaceuticals Inc | 36.15M |